| Dr Kristin Lundsten, DNP, MSN, PMNP-BC | |
|
400 Massasoit Ave Ste 305, East Providence, RI 02914-2012 | |
| (401) 294-0451 | |
| Not Available |
| Full Name | Dr Kristin Lundsten |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 12 Years |
| Location | 400 Massasoit Ave Ste 305, East Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104377365 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN36091 (Rhode Island) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | APRN02640 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ricbt, Inc. | 7517854995 | 31 |
News Archive
Today, Augmedix announced that it has received venture funding from DCM and Emergence Capital Partners. The funding closed on 31-Aug-2013. Founded by CEO Ian Shakil and Chief Product Officer Pelu Tran, Augmedix - a service powered by Google Glass - reclaims the hours physicians spend on the computer entering or retrieving data from electronic health records and refocuses them on what matters most: patient care.
Boys are more likely to receive the quadrivalent human papillomavirus vaccine if their mothers receive flu shots or Pap screenings, according to a Kaiser Permanente study published in the American Journal of Public Health.
Synergetics USA, Inc., announced today the signing of a pair of agreements with Alcon Laboratories, Inc. granting Alcon a license to sell certain products manufactured by Synergetics for worldwide distribution on a co-exclusive basis throughout the extensive Alcon network and covering the terms of supply of such products to Alcon by Synergetics.
Health care and government organizations call for routine collection of sexual orientation and gender identity information in the clinical setting.
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
› Verified 7 days ago
| Entity Name | Ricbt, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780776476 PECOS PAC ID: 7517854995 Enrollment ID: O20040301000979 |
News Archive
Today, Augmedix announced that it has received venture funding from DCM and Emergence Capital Partners. The funding closed on 31-Aug-2013. Founded by CEO Ian Shakil and Chief Product Officer Pelu Tran, Augmedix - a service powered by Google Glass - reclaims the hours physicians spend on the computer entering or retrieving data from electronic health records and refocuses them on what matters most: patient care.
Boys are more likely to receive the quadrivalent human papillomavirus vaccine if their mothers receive flu shots or Pap screenings, according to a Kaiser Permanente study published in the American Journal of Public Health.
Synergetics USA, Inc., announced today the signing of a pair of agreements with Alcon Laboratories, Inc. granting Alcon a license to sell certain products manufactured by Synergetics for worldwide distribution on a co-exclusive basis throughout the extensive Alcon network and covering the terms of supply of such products to Alcon by Synergetics.
Health care and government organizations call for routine collection of sexual orientation and gender identity information in the clinical setting.
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
› Verified 7 days ago
| Entity Name | Foundations For Wellness, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194404657 PECOS PAC ID: 5698122059 Enrollment ID: O20240301003131 |
News Archive
Today, Augmedix announced that it has received venture funding from DCM and Emergence Capital Partners. The funding closed on 31-Aug-2013. Founded by CEO Ian Shakil and Chief Product Officer Pelu Tran, Augmedix - a service powered by Google Glass - reclaims the hours physicians spend on the computer entering or retrieving data from electronic health records and refocuses them on what matters most: patient care.
Boys are more likely to receive the quadrivalent human papillomavirus vaccine if their mothers receive flu shots or Pap screenings, according to a Kaiser Permanente study published in the American Journal of Public Health.
Synergetics USA, Inc., announced today the signing of a pair of agreements with Alcon Laboratories, Inc. granting Alcon a license to sell certain products manufactured by Synergetics for worldwide distribution on a co-exclusive basis throughout the extensive Alcon network and covering the terms of supply of such products to Alcon by Synergetics.
Health care and government organizations call for routine collection of sexual orientation and gender identity information in the clinical setting.
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristin Lundsten, DNP, MSN, PMNP-BC 22 Christine Dr, Barrington, RI 02806-3226 Ph: (401) 603-6234 | Dr Kristin Lundsten, DNP, MSN, PMNP-BC 400 Massasoit Ave Ste 305, East Providence, RI 02914-2012 Ph: (401) 294-0451 |
News Archive
Today, Augmedix announced that it has received venture funding from DCM and Emergence Capital Partners. The funding closed on 31-Aug-2013. Founded by CEO Ian Shakil and Chief Product Officer Pelu Tran, Augmedix - a service powered by Google Glass - reclaims the hours physicians spend on the computer entering or retrieving data from electronic health records and refocuses them on what matters most: patient care.
Boys are more likely to receive the quadrivalent human papillomavirus vaccine if their mothers receive flu shots or Pap screenings, according to a Kaiser Permanente study published in the American Journal of Public Health.
Synergetics USA, Inc., announced today the signing of a pair of agreements with Alcon Laboratories, Inc. granting Alcon a license to sell certain products manufactured by Synergetics for worldwide distribution on a co-exclusive basis throughout the extensive Alcon network and covering the terms of supply of such products to Alcon by Synergetics.
Health care and government organizations call for routine collection of sexual orientation and gender identity information in the clinical setting.
Shire plc, the global specialty biopharmaceutical company, announced today that it will present key scientific data on its Attention-Deficit/Hyperactivity Disorder (ADHD) treatments, INTUNIV(TM) (guanfacine) Extended Release Tablets, Vyvanse®( ) (lisdexamfetamine dimesylate) Capsules CII, and Daytrana®( ) (methylphenidate transdermal system) CII, at a national meeting of psychiatrists to be held October 27 - November 1 in Honolulu.
› Verified 7 days ago
Michelle L Fox, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 Warren Ave Ste 401, East Providence, RI 02914 Phone: 401-330-2480 | |
Regina B Monteiro, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 950 Warren Ave Fl 2, East Providence, RI 02914 Phone: 401-606-1006 | |
Danielle Barry, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Kettle Point Ave, East Providence, RI 02914 Phone: 401-457-1500 Fax: 401-349-4373 | |
Taylor Selke, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 Massasoit Ave Ste 305, East Providence, RI 02914 Phone: 401-294-0451 | |
Ann Garris, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 450 Veterans Memorial Pkwy, Bldg. 4, East Providence, RI 02914 Phone: 401-435-3400 Fax: 401-435-3586 | |
Cara Beth Cavazza, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1 Office Pkwy, East Providence, RI 02914 Phone: 401-435-3325 | |
Sarah Madeline Bertsch, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Kettle Point Ave, East Providence, RI 02914 Phone: 401-457-1500 |